Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours.
The product of the nm23-H1 gene, reported to be related to the metastatic potential of tumour cells, was recently identified as the nucleoside diphosphate (NDP) kinase A (Gilles et al., 1991, J Biol Chem, 266, 8784-8789). An analysis of the enzyme by activity measurement and immunological techniques using polyclonal antibodies raised against the NDP kinase A purified from human erythrocytes, was performed on 39 human tissue specimens. Markedly increased activity and higher level of the protein were observed in extracts of solid tumours as compared to the corresponding normal tissues (P less than 0.01). An intense immunolabelling of tumoral cells was observed in sections of the malignant tumours and of some but not all benign neoplasia. The staining is observed in noninvasive and invasive ductal breast carcinomas with or without lymph node involvement as well as in colon and cervix carcinomas and in a case of metastatic melanoma. Therefore, NDP kinase A level is increased in neoplastic tissues but no correlation with metastatic potential could be demonstrated.
Lacombe
M L
ML
Unité de Biochimie Cellulaire, Institut Pasteur, Paris, France.
Sastre-Garau
X
X
Lascu
I
I
Vonica
A
A
Wallet
V
V
Thiery
J P
JP
Véron
M
M
D015153:Blotting, Western; D001943:Breast Neoplasms / Q000201:enzymology*; D003110:Colonic Neoplasms / Q000201:enzymology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008198:Lymph Nodes / Q000201:enzymology; D008545:Melanoma / Q000201:enzymology; D009701:Nucleoside-Diphosphate Kinase / Q000378:metabolism*; D002583:Uterine Cervical Neoplasms / Q000201:enzymology
D009701:Nucleoside-Diphosphate Kinase